NeoPhore closes oversubscribed Series B extension round with additional funding from Bristol Myers Squibb
Published on 08/07/2025 at 18:08 | prnewswire.co.uk
Additional funding will be used to explore novel biology around the MMR pathway and accelerate progression of the lead program into candidate selectionView original content:https://www.prnewswire.co.uk/news-releases/neophore-closes-oversubscribed-series-b-extension-round-with-additional-funding-from-bristol-myers-squibb-302151962.html
en | US1101221083 | NEOPHORE | boerse | 67929587 |
